Shanghai Pharmaceutical Co., Ltd. To Raise $1.2 Bln In HK to Fund M&A

SHANGHAI, Sept 8 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd (601607.SS), the Chinese partner of Roche Holding AG (ROG.VX), said on Wednesday it plans to raise at least 8 billion yuan ($1.2 billion) through a public share offering in Hong Kong to fund acquisitions.